Parallax Volatility Advisers, L.P. Geron Corp Call Options Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$2.03 - $2.42 $174,782 - $208,362	86,100 New	86,100 $208,000
Q1 2019 May 15, 2019	SELL	$1.01 - $1.83 $165,337 - $299,571	-163,700 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$0.98 - $1.85 $53,900 - $101,750	-55,000 Reduced 25.15%	163,700 $164,000
Q3 2018 Nov 14, 2018	BUY	$1.76 - $6.38 $288,112 - $1.04 Million	163,700 Added 297.64%	218,700 $384,000
Q2 2018 Aug 14, 2018	BUY	$3.29 - $4.82 $180,950 - $265,100	55,000 New	55,000 $188,000

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.53B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.